GSTM1 and anemia (phenotype): Although point-of-care hemoglobin tests still require costly consumables like cuvettes, an investment in these point of care devices for measuring Hb would lead to improved inpatient care and help manage limited blood stocks in resource limited settings where mortality from severe anaemia remains unacceptably high.